328 related articles for article (PubMed ID: 9673245)
21. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K
J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
[TBL] [Abstract][Full Text] [Related]
22. Campylobacter jejuni isolates from Japanese patients with Guillain-Barré syndrome.
Saida T; Kuroki S; Hao Q; Nishimura M; Nukina M; Obayashi H
J Infect Dis; 1997 Dec; 176 Suppl 2():S129-34. PubMed ID: 9396696
[TBL] [Abstract][Full Text] [Related]
23. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome.
Aspinall GO; McDonald AG; Pang H; Kurjanczyk LA; Penner JL
Biochemistry; 1994 Jan; 33(1):241-9. PubMed ID: 8286348
[TBL] [Abstract][Full Text] [Related]
24. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure.
Aspinall GO; Fujimoto S; McDonald AG; Pang H; Kurjanczyk LA; Penner JL
Infect Immun; 1994 May; 62(5):2122-5. PubMed ID: 8168981
[TBL] [Abstract][Full Text] [Related]
25. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
[TBL] [Abstract][Full Text] [Related]
26. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome.
Jacobs BC; Hazenberg MP; van Doorn PA; Endtz HP; van der Meché FG
J Infect Dis; 1997 Mar; 175(3):729-33. PubMed ID: 9041356
[TBL] [Abstract][Full Text] [Related]
27. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
28. Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies.
Koga M; Gilbert M; Li J; Yuki N
PLoS One; 2015; 10(4):e0124004. PubMed ID: 25867522
[TBL] [Abstract][Full Text] [Related]
29. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome.
Yuki N
Cell Mol Life Sci; 2000 Apr; 57(4):527-33. PubMed ID: 11130452
[TBL] [Abstract][Full Text] [Related]
30. [A patient with Guillain-Barré syndrome in association with Campylobacter jejuni enteritis (PEN19:LIO7) in a patient with HLA-B52 antigen].
Kaida K; Yuki N; Takahashi M; Kamakura K; Nagata N
Rinsho Shinkeigaku; 1994 Jul; 34(7):733-5. PubMed ID: 7955736
[TBL] [Abstract][Full Text] [Related]
31. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
[TBL] [Abstract][Full Text] [Related]
32. Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.
Islam Z; Gilbert M; Mohammad QD; Klaij K; Li J; van Rijs W; Tio-Gillen AP; Talukder KA; Willison HJ; van Belkum A; Endtz HP; Jacobs BC
PLoS One; 2012; 7(8):e43976. PubMed ID: 22952833
[TBL] [Abstract][Full Text] [Related]
33. Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3.
Salloway S; Mermel LA; Seamans M; Aspinall GO; Nam Shin JE; Kurjanczyk LA; Penner JL
Infect Immun; 1996 Aug; 64(8):2945-9. PubMed ID: 8757818
[TBL] [Abstract][Full Text] [Related]
34. Characterization of Campylobacter jejuni isolates from patients with Guillain-Barré syndrome.
Nishimura M; Nukina M; Kuroki S; Obayashi H; Ohta M; Ma JJ; Saida T; Uchiyama T
J Neurol Sci; 1997 Dec; 153(1):91-9. PubMed ID: 9455985
[TBL] [Abstract][Full Text] [Related]
35. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.
Ang CW; Laman JD; Willison HJ; Wagner ER; Endtz HP; De Klerk MA; Tio-Gillen AP; Van den Braak N; Jacobs BC; Van Doorn PA
Infect Immun; 2002 Mar; 70(3):1202-8. PubMed ID: 11854201
[TBL] [Abstract][Full Text] [Related]
36. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
Shu XM; Cai FC; Zhang XP
Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
[TBL] [Abstract][Full Text] [Related]
37. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis.
Koga M; Yuki N; Hirata K
J Neuroimmunol; 1999 May; 96(2):245-50. PubMed ID: 10337924
[TBL] [Abstract][Full Text] [Related]
38. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
Koga M; Yuki N; Takahashi M; Saito K; Hirata K
J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
[TBL] [Abstract][Full Text] [Related]
39. Brucella melitensis infection associated with Guillain-Barré syndrome through molecular mimicry of host structures.
Watanabe K; Kim S; Nishiguchi M; Suzuki H; Watarai M
FEMS Immunol Med Microbiol; 2005 Aug; 45(2):121-7. PubMed ID: 16051063
[TBL] [Abstract][Full Text] [Related]
40. Host factors determine anti-GM1 response following oral challenge of chickens with Guillain-Barré syndrome derived Campylobacter jejuni strain GB11.
Ang CW; Dijkstra JR; de Klerk MA; Endtz HP; van Doorn PA; Jacobs BC; Jeurissen SH; Wagenaar JA
PLoS One; 2010 Mar; 5(3):e9820. PubMed ID: 20339556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
